JP2021504321A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021504321A5 JP2021504321A5 JP2020527951A JP2020527951A JP2021504321A5 JP 2021504321 A5 JP2021504321 A5 JP 2021504321A5 JP 2020527951 A JP2020527951 A JP 2020527951A JP 2020527951 A JP2020527951 A JP 2020527951A JP 2021504321 A5 JP2021504321 A5 JP 2021504321A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- antigen
- antibody
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1719447.3A GB201719447D0 (en) | 2017-11-23 | 2017-11-23 | Pharmaceutical composition |
| GB1719447.3 | 2017-11-23 | ||
| PCT/EP2018/081129 WO2019101582A1 (en) | 2017-11-23 | 2018-11-13 | Formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021504321A JP2021504321A (ja) | 2021-02-15 |
| JP2021504321A5 true JP2021504321A5 (https=) | 2021-07-26 |
| JP6955632B2 JP6955632B2 (ja) | 2021-10-27 |
Family
ID=60950516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020527951A Active JP6955632B2 (ja) | 2017-11-23 | 2018-11-13 | 製剤 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US11857625B2 (https=) |
| EP (1) | EP3713602A1 (https=) |
| JP (1) | JP6955632B2 (https=) |
| KR (1) | KR102767553B1 (https=) |
| CN (1) | CN111511399A (https=) |
| AR (1) | AR113534A1 (https=) |
| AU (1) | AU2018371056B2 (https=) |
| BR (1) | BR112020009866A2 (https=) |
| CA (1) | CA3082832C (https=) |
| CL (1) | CL2020001307A1 (https=) |
| CO (1) | CO2020006120A2 (https=) |
| EA (1) | EA202091295A1 (https=) |
| GB (1) | GB201719447D0 (https=) |
| IL (1) | IL274719B2 (https=) |
| MX (1) | MX2020004747A (https=) |
| MY (1) | MY194682A (https=) |
| RU (1) | RU2020120547A (https=) |
| SG (1) | SG11202004601YA (https=) |
| WO (1) | WO2019101582A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| CN120241997A (zh) | 2019-02-18 | 2025-07-04 | 伊莱利利公司 | 治疗性抗体制剂 |
| CN110585430B (zh) * | 2019-09-29 | 2023-09-08 | 华博生物医药技术（上海）有限公司 | 一种人源化抗人il-17a单克隆抗体的药物组合物 |
| CN112915201B (zh) | 2019-12-06 | 2023-06-27 | 珠海市丽珠单抗生物技术有限公司 | 包含抗il-17抗体的液体制剂 |
| CN113769082A (zh) * | 2020-06-10 | 2021-12-10 | 上海君实生物医药科技股份有限公司 | 抗il-17a抗体药物组合物及其用途 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007019232A2 (en) | 2005-08-03 | 2007-02-15 | Immunogen, Inc. | Immunoconjugate formulations |
| GB0620729D0 (en) * | 2006-10-18 | 2006-11-29 | Ucb Sa | Biological products |
| WO2009120684A1 (en) | 2008-03-25 | 2009-10-01 | Medimmune, Llc | Antibody formulation |
| BR112012013148A2 (pt) | 2009-12-29 | 2017-03-21 | F Hoffmann - La Roche Ag | formulação farmacêutica e uso |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| NZ602685A (en) | 2010-03-01 | 2014-10-31 | Cytodyn Inc | Concentrated protein formulations and uses thereof |
| SMT202000095T1 (it) * | 2010-05-14 | 2020-03-13 | Amgen Inc | Formulazioni di anticorpi anti-sclerostina ad alta concentrazione |
| FR2962650B1 (fr) | 2010-07-19 | 2013-04-05 | Lab Francais Du Fractionnement | Composition d'immunoglobulines humaines concentrees |
| BR112013011176A2 (pt) * | 2010-11-05 | 2020-09-01 | Novartis Ag | métodos de tratamento de artrite reumatoide usando antagonistas de il-17 |
| ME02734B (me) * | 2011-01-14 | 2017-10-20 | Ucb Biopharma Sprl | Antitelo koje vezuje il-17a i il-17f |
| EA201590061A1 (ru) * | 2012-06-21 | 2015-05-29 | Юсб Фарма С.А. | Фармацевтическая композиция |
| WO2016070062A2 (en) * | 2014-10-31 | 2016-05-06 | Genentech, Inc. | Anti-il-17a and il-17f cross reactive antibody variants and compositions comprising and methods of making and using same |
| AR103173A1 (es) * | 2014-12-22 | 2017-04-19 | Novarits Ag | Productos farmacéuticos y composiciones líquidas estables de anticuerpos il-17 |
| RS64263B1 (sr) | 2015-08-19 | 2023-07-31 | Astrazeneca Ab | Stabilna anti-ifnar1 formulacija |
| CN116059350A (zh) * | 2015-10-27 | 2023-05-05 | Ucb生物制药有限责任公司 | 使用抗-il-17a/f抗体的治疗方法 |
| GB201522391D0 (en) * | 2015-12-18 | 2016-02-03 | Ucb Biopharma Sprl | Antibody molecules |
| EP3443346B1 (en) | 2016-04-13 | 2023-08-30 | Medimmune, LLC | Use of amino acids as stabilizing compounds in pharmaceutical compositions containing high concentrations of protein-based therapeutic agents |
| ES2905917T3 (es) | 2016-09-14 | 2022-04-12 | Beijing Hanmi Pharmaceutical Co Ltd | Anticuerpo que se une específicamente a IL-17A y fragmento funcional del mismo |
-
2017
- 2017-11-23 GB GBGB1719447.3A patent/GB201719447D0/en not_active Ceased
-
2018
- 2018-11-13 US US16/765,786 patent/US11857625B2/en active Active
- 2018-11-13 CA CA3082832A patent/CA3082832C/en active Active
- 2018-11-13 MY MYPI2020002408A patent/MY194682A/en unknown
- 2018-11-13 AU AU2018371056A patent/AU2018371056B2/en active Active
- 2018-11-13 BR BR112020009866-3A patent/BR112020009866A2/pt unknown
- 2018-11-13 EP EP18807571.7A patent/EP3713602A1/en active Pending
- 2018-11-13 WO PCT/EP2018/081129 patent/WO2019101582A1/en not_active Ceased
- 2018-11-13 MX MX2020004747A patent/MX2020004747A/es unknown
- 2018-11-13 IL IL274719A patent/IL274719B2/en unknown
- 2018-11-13 KR KR1020207017469A patent/KR102767553B1/ko active Active
- 2018-11-13 EA EA202091295A patent/EA202091295A1/ru unknown
- 2018-11-13 CN CN201880075625.0A patent/CN111511399A/zh active Pending
- 2018-11-13 JP JP2020527951A patent/JP6955632B2/ja active Active
- 2018-11-13 SG SG11202004601YA patent/SG11202004601YA/en unknown
- 2018-11-13 RU RU2020120547A patent/RU2020120547A/ru unknown
- 2018-11-22 AR ARP180103417A patent/AR113534A1/es unknown
-
2020
- 2020-05-18 CL CL2020001307A patent/CL2020001307A1/es unknown
- 2020-05-18 CO CONC2020/0006120A patent/CO2020006120A2/es unknown
-
2023
- 2023-12-22 US US18/394,323 patent/US20240123065A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021504321A5 (https=) | ||
| RU2020120547A (ru) | Препарат | |
| JP2022082757A (ja) | 抗－ｃｄ３抗体製剤 | |
| JP2018521691A5 (https=) | ||
| ES2546800T3 (es) | Molécula de anticuerpo mejorada contra el receptor de IL-6 | |
| TWI891945B (zh) | 抗tslp抗體藥物組合物及其用途 | |
| CN106496324B (zh) | 一种抗呼吸道合胞病毒的全人源抗体 | |
| JP2019521647A5 (https=) | ||
| JP2016539176A5 (https=) | ||
| RU2018106364A (ru) | Антитела против рецептора tfr и их применение при лечении пролиферативных и воспалительных расстройств | |
| JP2018502060A5 (https=) | ||
| JP2019162119A5 (https=) | ||
| JP2017532037A5 (https=) | ||
| HRP20150799T1 (hr) | Sastavi i postupci za protutijela protiv komplementnog proteina c5 | |
| JP2016065094A5 (https=) | ||
| JP2019503706A5 (https=) | ||
| ME00519B (me) | Antitijela visokog afiniteta prema humanom il-6 receptoru | |
| JP2020537520A5 (https=) | ||
| JP2023505492A5 (https=) | ||
| JP2016520595A5 (https=) | ||
| JP2015501830A5 (https=) | ||
| CN103619870B (zh) | 乙型肝炎病毒表面抗原的表位及其用途 | |
| HRP20230605T1 (hr) | Protutijela protiv interferona beta i njihova upotreba | |
| RU2019123112A (ru) | Анти-il-5 антитела | |
| WO2018184593A1 (zh) | 用于治疗乙肝感染及相关疾病的抗体 |